PBYI earnings date and last-quarter result: last quarter beat, P/E 15.86. Updated 2026-07-23.
Puma Biotechnology (PBYI) Research Hub
Puma Biotechnology (PBYI) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 10.85 USD (-1.54%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 15.86, market cap 0.42B. This hub links to the full technical, earnings and options research available for PBYI.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 10.85 USD (-1.54%) |
| 52-week range | 7 USD – 11.38 USD |
| Trend regime | Range |
| 14-day RSI | 67.4 (Bullish) |
| Trailing P/E | 15.86 |
| Market cap | 0.42B |
| Dividend yield | 0.00% |
Available research for PBYI
Covered Call on PBYI: how it works, illustrative setup around the real 10.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PBYI: how it works, illustrative setup around the real 10.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PBYI: how it works, illustrative setup around the real 10.85 USD price, max profit/loss, breakeven and when to use it. Educational.
PBYI technical analysis: range, last 10.85 USD, RSI 67.4, 52w range 7 USD–11.38 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PBYI in?
Puma Biotechnology (PBYI) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is PBYI in an uptrend or downtrend?
As of 2026-10-26, PBYI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PBYI's trailing P/E ratio?
PBYI's trailing P/E is 15.86, with a market cap of 0.42B. See the earnings research page for full valuation detail.